Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin Alfa vs Daily Rec FSH in Poor Responders
NCT02046655Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jan 2011
- Primary completion
- Mar 2014
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of corifollitropin alfa in female infertility (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoint: Total number of retrieved oocytes. Started Jan 2011; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT02046655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046655.